title: Atorvastatin is an effective and well-tolerated treatment alternative for patients not achieving target lipid goals with simvastatin.
authors: St. Luke's Hospital, Tobey Hospital, Southcoast Hospitals Group, New Bedford, Mass., USA. eugeniok@southcoast.org
authors: Kenneth R
authors: KR
authors: Eugenio
authors: George
authors: G
authors: Alexis
authors: Andrew F
authors: AF
authors: Kelliher
authors: Robert G
authors: RG
authors: Henault
authors: James A
authors: JA
authors: Vieira
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D012189:Retrospective Studies; D019821:Simvastatin / Q000009:adverse effects*
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D002784:Cholesterol; D000069059:Atorvastatin; D019821:Simvastatin